Novocure Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -133.3% | – | – | – | -187.5% | – | – | – | |
| – | -2.9% | +3.4% | +1.5% | -14.0% | +26.3% | -207.2% | – | -179.5% | – | -64.3% | +13.7% | – | |
| – | -33.8% | +95.5% | -6.6% | -1.5% | +100.1% | -52.9% | -11.5% | +12.2% | -32.4% | +218.0% | -73.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +257.1% | -213.5% | – | +359.5% | -66.9% | -697.0% | – | – | -149.0% | – | – | – | |
| – | -6.0% | +72.8% | -2.9% | -6.7% | -16.3% | +18.7% | -48.3% | +3.1% | -13.4% | +5.2% | +34.2% | – | |
| – | +470.7% | +150.0% | -252.1% | – | -317.9% | -70.9% | – | +98.5% | +370.8% | -97.7% | -182.3% | – | |
| – | – | – | – | – | – | – | – | – | -661.1% | -100.0% | – | – | |
| – | +63.1% | -88.8% | +40,893.9% | -99.9% | +2,585.0% | +95.4% | -54.5% | +4,111.0% | -656.6% | -100.0% | – | – | |
| – | – | +149.6% | -234.5% | – | -211.3% | – | – | +748.0% | -225.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -253.5% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.